Covered recipient · General Payments record
PATRICK N ANDRE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$1,407.79
- Reported across 83 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $374.48 | 25 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $139.25 | 11 |
| Acerta Pharma LLC | $53.31 | 3 |
| Novo Nordisk AS | $48.63 | 2 |
| Amgen Inc. | $45.45 | 3 |
| GlaxoSmithKline, LLC. | $31.83 | 2 |
| Lilly USA, LLC | $30.51 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.71 | 1 |
| Phathom Pharmaceuticals, Inc. | $7.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.62 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418200 | CMS |
| ABBVIE INC. | $21.95 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418202 | CMS |
| ABBVIE INC. | $7.64 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418204 | CMS |
| ABBVIE INC. | $19.75 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418206 | CMS |
| ABBVIE INC. | $7.39 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418208 | CMS |
| ABBVIE INC. | $4.89 | 09/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418210 | CMS |
| ABBVIE INC. | $12.20 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418212 | CMS |
| ABBVIE INC. | $18.98 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418214 | CMS |
| ABBVIE INC. | $9.30 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418216 | CMS |
| ABBVIE INC. | $9.08 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418218 | CMS |
| ABBVIE INC. | $15.45 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201418220 | CMS |
| Amgen Inc. | $15.70 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228632540 | CMS |
| Amgen Inc. | $16.06 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228632538 | CMS |
| Amgen Inc. | $13.69 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227126772 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.15 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206212953 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.15 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206760527 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.01 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207276434 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.71 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222895845 | CMS |
| GlaxoSmithKline, LLC. | $17.90 | 05/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190659596 | CMS |
| GlaxoSmithKline, LLC. | $13.93 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190649302 | CMS |
| Lilly USA, LLC | $16.98 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186790887 | CMS |
| Lilly USA, LLC | $13.53 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186836886 | CMS |
| Novo Nordisk Inc | $18.10 | 01/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188853748 | CMS |
| Novo Nordisk Inc | $30.53 | 08/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188441789 | CMS |
| Phathom Pharmaceuticals, Inc. | $7.79 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219333424 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.